Search
Products
Community
Markets
Brokers
More
EN
Get started
Markets
/
/
Financials
A
A
Anavex Life Sciences Corp.
A1411S
Lang & Schwarz Tradecenter
A1411S
Lang & Schwarz Tradecenter
A1411S
Lang & Schwarz Tradecenter
A1411S
Lang & Schwarz Tradecenter
Market closed
Market closed
No trades
EUR
R
EUR
No trades
See on Supercharts
Overview
Financials
News
Ideas
Discussions
Technicals
Forecast
Seasonals
A1411S fundamentals
Overview
Statements
Statistics
Dividends
Earnings
Revenue
More
Anavex Life Sciences Corp. financial statements, including revenue, expenses, and profit
The annual and quarterly earnings report below will help you understand the performance of A1411S.
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−16.00 M
−12.00 M
−8.00 M
−4.00 M
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Income statement
Balance sheet
Cash flow
Annual
Annual
Quarterly
Quarterly
More
More
Currency: EUR
Q2 '17
Mar 2017
Q3 '17
Jun 2017
Q4 '17
Sep 2017
Q1 '18
Dec 2017
Q2 '18
Mar 2018
Q3 '18
Jun 2018
Q4 '18
Sep 2018
Q1 '19
Dec 2018
Q2 '19
Mar 2019
Q3 '19
Jun 2019
Q4 '19
Sep 2019
Q1 '20
Dec 2019
Q2 '20
Mar 2020
Q3 '20
Jun 2020
Q4 '20
Sep 2020
Q1 '21
Dec 2020
Q2 '21
Mar 2021
Q3 '21
Jun 2021
Q4 '21
Sep 2021
Q1 '22
Dec 2021
Q2 '22
Mar 2022
Q3 '22
Jun 2022
Q4 '22
Sep 2022
Q1 '23
Dec 2022
Q2 '23
Mar 2023
Q3 '23
Jun 2023
Q4 '23
Sep 2023
Q1 '24
Dec 2023
Q2 '24
Mar 2024
Q3 '24
Jun 2024
Q4 '24
Sep 2024
Q1 '25
Dec 2024
TTM
Total revenue
YoY growth
0.00
—
0.00
—
0.00
—
0.00
—
0.00
—
0.00
—
0.00
—
0.00
—
—
Cost of goods sold
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
Gross profit
YoY growth
0.00
—
0.00
—
0.00
—
0.00
—
0.00
—
0.00
—
0.00
—
0.00
—
—
Operating expenses (excl. COGS)
−13.09 M
−12.41 M
−11.97 M
−10.23 M
−11.60 M
−13.75 M
−12.88 M
−13.13 M
−53.30 M
Operating income
YoY growth
−13.09 M
−25.76%
−12.41 M
−4.35%
−11.97 M
+23.25%
−10.23 M
+28.82%
−11.60 M
+11.38%
−13.75 M
−10.85%
−12.88 M
−7.57%
−13.13 M
−28.32%
−53.30 M
Non-operating income, total
352.64 K
1.58 M
1.68 M
1.96 M
1.49 M
1.79 M
1.70 M
1.03 M
6.27 M
Pretax income
YoY growth
−12.74 M
−25.38%
−10.82 M
+12.50%
−10.29 M
+33.08%
−8.27 M
+35.51%
−10.11 M
+20.61%
−11.96 M
−10.49%
−11.18 M
−8.58%
−12.10 M
−46.26%
−47.03 M
Equity in earnings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
Taxes
645.58 K
480.26 K
694.36 K
459.35 K
340.13 K
553.63 K
740.07 K
397.98 K
2.12 M
Non-controlling/minority interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
After tax other income/expense
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
Net income before discontinued operations
−12.09 M
−10.34 M
−9.60 M
−7.81 M
−9.77 M
−11.40 M
−10.44 M
−11.70 M
−44.91 M
Discontinued operations
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
Net income
YoY growth
−12.09 M
−28.21%
−10.34 M
+12.37%
−9.60 M
+34.17%
−7.81 M
+35.55%
−9.77 M
+19.18%
−11.40 M
−10.26%
−10.44 M
−8.72%
−11.70 M
−49.76%
−44.91 M
Dilution adjustment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
Preferred dividends
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
Diluted net income available to common stockholders
−12.09 M
−10.34 M
−9.60 M
−7.81 M
−9.77 M
−11.40 M
−10.44 M
−11.70 M
−44.91 M
Basic earnings per share (Basic EPS)
YoY growth
−0.15
−24.84%
−0.13
+16.07%
−0.12
+37.79%
−0.10
+38.81%
−0.12
+23.26%
−0.13
−5.48%
−0.12
−5.06%
−0.14
−45.00%
—
Diluted earnings per share (Diluted EPS)
YoY growth
−0.15
−24.84%
−0.13
+16.07%
−0.12
+37.79%
−0.10
+38.81%
−0.12
+23.26%
−0.13
−5.48%
−0.12
−5.06%
−0.14
−45.00%
−0.53
Average basic shares outstanding
78.30 M
80.88 M
81.97 M
82.08 M
82.46 M
84.54 M
84.80 M
84.81 M
—
Diluted shares outstanding
78.30 M
80.88 M
81.97 M
82.08 M
82.46 M
84.54 M
84.80 M
84.81 M
—
EBITDA
YoY growth
−13.09 M
−25.76%
−12.41 M
−4.35%
−11.97 M
+23.25%
−10.23 M
+28.82%
−11.60 M
+11.38%
−13.75 M
−10.85%
−12.88 M
−7.57%
−13.13 M
−28.32%
−53.30 M
EBIT
YoY growth
−13.09 M
−25.76%
−12.41 M
−4.35%
−11.97 M
+23.25%
−10.23 M
+28.82%
−11.60 M
+11.38%
−13.75 M
−10.85%
−12.88 M
−7.57%
−13.13 M
−28.32%
−53.30 M
Total operating expenses
−13.09 M
−12.41 M
−11.97 M
−10.23 M
−11.60 M
−13.75 M
−12.88 M
−13.13 M
−53.30 M